InnovAge (INNV)
(Delayed Data from NSDQ)
$5.97 USD
-0.21 (-3.40%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $5.90 -0.07 (-1.17%) 5:24 PM ET
3-Hold of 5 3
C Value B Growth NA Momentum NA VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.97 USD
-0.21 (-3.40%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $5.90 -0.07 (-1.17%) 5:24 PM ET
3-Hold of 5 3
C Value B Growth NA Momentum NA VGM
Zacks News
CareDx (CDNA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareDx (CDNA) delivered earnings and revenue surprises of -225% and 1%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for InnovAge (INNV) Stock Options
by Zacks Equity Research
Investors need to pay close attention to InnovAge (INNV) stock based on the movements in the options market lately.